Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Non-Current Liabilities (2019 - 2022)

Historic Total Non-Current Liabilities for Pulmonx (LUNG) over the last 4 years, with Q3 2022 value amounting to $38.7 million.

  • Pulmonx's Total Non-Current Liabilities changed N/A to $38.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $38.7 million, marking a year-over-year change of. This contributed to the annual value of $41.8 million for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q3 2022, Pulmonx's Total Non-Current Liabilities is $38.7 million.
  • In the past 5 years, Pulmonx's Total Non-Current Liabilities ranged from a high of $68.6 million in Q3 2020 and a low of $34.4 million during Q4 2019
  • Moreover, its 4-year median value for Total Non-Current Liabilities was $40.4 million (2022), whereas its average is $44.1 million.